Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20582588 | 0.96 | CA1 (0.56) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL5026807 | 0.90 | CA2 (0.70) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL11547365 | 0.89 | GAA (0.54) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL11544837 | 0.85 | GAA (0.54) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL20710745 | 0.82 | CA1 (0.62) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL3294100 | 0.82 | TSHR (0.69) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL25299492 | 0.81 | TSHR (0.48) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL22322000 | 0.81 | CA2 (0.57) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL906952 | 0.81 | CA2 (0.57) | CA2CA1BCHEACHEMEN1 | |
| SCHEMBL556916 | 0.81 | CA1 (0.57) | CA2CA1BCHEACHEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050259-A | Silicon-phosphorus block intrinsic flame-retardant polyurea material and preparation method thereof | 北京化工大学 | 2023-11-14 | — | — | CN | claimed |
| CN-118240396-A | Reinforced fiber for composite floor and preparation method thereof | 广西大自然智能家居有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117050259-A | Silicon-phosphorus block intrinsic flame-retardant polyurea material and preparation method thereof | 北京化工大学 | 2023-11-14 | — | — | CN | disclosed |
| CN-108342058-B | The master batch of VOCs in recycled polyester can be removed under illumination and no light condition | 东华大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-108396404-B | Low VOC type Regenerated Polyester Fibres and preparation method thereof | 优彩环保资源科技股份有限公司 | 2019-06-11 | — | — | CN | disclosed |
| US-20080319209-A1 | Process for Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans | BAYER CROPSCIENCE AG (DE) | 2008-12-25 | — | — | US | disclosed |
| US-20080319209-A1 | Process for Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans | BAYER CROPSCIENCE AG (DE) | 2008-12-25 | — | — | US | disclosed |
| WO-2007005450-A2 | IMPROVED PROCESS FOR PREPARING (DISUBSTITUTEDPROPENYL) PHENYLALKYL SUBSTITUTED HETEROCYCLES | BAYER CROPSCIENCE AG (DE) | 2007-01-11 | — | — | WO | disclosed |
| EP-0574174-B1 | Angiotensin II antagonists | LILLY CO ELI (US) | 2003-08-13 | — | — | EP | disclosed |
| US-6090889-A | FATTY ALCOHOL OR ETHYLENE VINYL ACETATE ARE GRAFTED ONTO AN ACRYLIC POLYMER | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2000-07-18 | — | — | US | disclosed |
| US-5693633-A | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| US-5612360-A | AROMATIC N-HETEROCYCLIC COMPOUNDS AS HYPOTENSIVE AGENTS WITH ACID GROUPS, SULFONYLCARBOXAMIDES OR TETRAZOLE GROUPS | ELI LILLY AND COMPANY (US) | 1997-03-18 | — | — | US | disclosed |
| US-5569768-A | USEFUL IN TREATING HYPERTENSION, CONGESTIVE HEART FAILURE, GLAUCOMA AND RENAL INSUFFICIENCY | ELI LILLY AND COMPANY (US) | 1996-10-29 | — | — | US | disclosed |
| US-5556981-A | Angiotensin II antagonist intermediates | ELI LILLY AND COMPANY (US) | 1996-09-17 | — | — | US | disclosed |
| US-5484780-A | CARDIOVASCULAR, HYPOTENSIVE | ELI LILLY AND COMPANY (US) | 1996-01-16 | — | — | US | disclosed |
| CN-1101908-A | Angiotensin II antagonists | LILLY CO ELI (US) | 1995-04-26 | — | — | CN | disclosed |
| US-5401851-A | Preparation of proline derivatives | ELI LILLY AND COMPANY (US) | 1995-03-28 | — | — | US | disclosed |
| CN-1085897-A | Angiotension II antagonists | LILLY CO ELI (US) | 1994-04-27 | — | — | CN | disclosed |
| EP-0574174-A2 | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1993-12-15 | — | — | EP | disclosed |
| EP-0573271-A1 | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319209-A1 | Process for Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans | CYP2F1, CYP4X1, C1S | CA2 4687/4885CA1 4822/4885BCHE 2776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.